TG Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:TGTX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 577.69 M656.69 M702.61 M1.03 B1.06 B 負債合計 355.33 M419.4 M426.18 M417.81 M415.23 M 純資産合計 222.36 M237.29 M276.43 M607.22 M648.02 M 負債および純資産合計 577.69 M656.69 M702.61 M1.03 B1.06 B 有利子負債合計 244.43 M244.73 M245.04 M245.34 M245.65 M 純負債 -66.57 M-31.47 M-33.86 M67.04 M46.15 M

ニュース

TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX)

BRIUMVI、高度活動性多発性硬化症患者に有効性を示す

BRIUMVI shows efficacy in highly active multiple sclerosis patients

TG Therapeutics、神経学会議でBRIUMVIデータを発表へ

TG Therapeutics to present BRIUMVI data at neurology meeting

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line

TG Therapeutics (TGTX) Misses Q4 Earnings Estimates

TG earnings missed by $0.23, revenue topped estimates

Briumviの成長加速でTG Therapeuticsが決算発表を控える

Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates

TG Therapeutics faces earnings test as Briumvi growth accelerates

TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release